A media briefing with experts from the Infectious Diseases Society of America to discuss IDSA’s updates to its COVID-19 Diagnostic Guidelines. 

Helene D. Gayle, MD, MPH, President & CEO of Chicago Community Trust, Kristen Ehresmann, RN, MPH, Director, Infectious. Disease Epidemiology, Prevention and Control Division at the Minnesota Department of Public Health and Helen Branswell, senior writer at STAT, will talk on a panel with the Center for Infectious Disease Research and Policy’s director Michael Osterholm on the topic of allocation and distribution of the COVID-19 vaccines. 

Hahn will address the role of the U.S. Food and Drug Administration in the COVID-19 response and best practices and lessons learned from the emergency response to date.

Join the National Press Club Journalism Institute and the National Press Club Communicators Committee for a candid conversation on the COVID vaccine: Communication challenges for public health efforts & reporters.

Science Writers in New York is excited to kick off 2021 with author and award-winning investigative journalist Gerald Posner (@geraldposner).

Posner will talk to SWINY co-chair David Levine (@dlloydlevine) about why the vaccine rollout is so slow, what can be done about it and whether altering the vaccine dose schedule makes sense.

We will be bringing together a wide range of expertise to highlight issues around the media reporting of research as well as the positive steps that can be taken to improve how research is reported in the media to avoid its misinterpretation and misuse. 

President-elect Joe Biden’s most urgent challenge is stemming COVID-19 in the U.S. What will be his strategy and priorities? Join Biden COVID-19 Advisory Board members Celine Gounder, MD, ScM ’00, and Loyce Pace, MPH ’05, for a special “Alumni Spotlight Series” webcast moderated by Global Health NOW editor-in-chief Brian W. Simpson, MPH ’13.

This episode of the NAJA Roundtable series will feature experts and reporters who will discuss common pitfalls and best practices when covering the pandemic in Indian Country. 

As the rollout of COVID-19 vaccines unfolds in the United States, numerous questions around distribution, supply, hesitancy and efficacy persist. And the stakes have never been higher, as numbers of deaths and cases repeatedly break records. In this discussion, experts will review the COVID-19 vaccine distribution plan, address safety concerns, explore upcoming expected vaccines, and discuss implications of virus variants.

How are misconceptions about vaccination—and the COVID-19 vaccines in particular—amplified and promulgated? What are effective strategies for combating misinformation to overcome vaccine hesitancy, especially in vulnerable populations? How can journalists and other science communicators more effectively articulate the benefits and risks of vaccination while maintaining their objectivity and integrity?

Friday, January 29 at 1 p.m. EST Hosted by the Alliance for Health Policy As of December 2020, 27% of…